Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 297 shares of common stock on September 9, 2026, in connection with a tax withholding obligation.

Key Highlights

  • Reporting person: Alaleh Nouri, EVP, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp.
  • Shares disposed: 297 shares of common stock sold on September 9, 2026, at a price of $20.953 per share.
  • Transaction type: Sell-to-cover for tax withholding obligations tied to the vesting of Restricted Stock Units on September 5, 2026.
  • Remaining ownership: 127,737 shares of common stock held directly following the transaction.
  • Filing signed: Jonathan Stone, Attorney-in-Fact for Alaleh Nouri, on September 10, 2026.

PROCEPT BioRobotics Officer Discloses RSU Vest-Related Share Sale

According to the Form 4 filed with the SEC on September 10, 2026, Alaleh Nouri, serving as EVP, CLO, and Corporate Secretary at PROCEPT BioRobotics Corp, disposed of 297 shares of the company's common stock on September 9, 2026, at a price of $20.953 per share. The filing identifies the transaction code as "S," indicating a sale of securities.

The filing's footnote explains that "the shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026." No open-market discretionary sale is indicated by the filing. Following the reported transaction, Nouri directly holds 127,737 shares of common stock, according to the filing.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed by one reporting person and was signed by Jonathan Stone as Attorney-in-Fact for Alaleh Nouri on September 10, 2026.

What Was Disclosed

The filing discloses a single disposition of 297 shares of PROCEPT BioRobotics common stock at $20.953 per share by EVP and CLO Alaleh Nouri on September 9, 2026, executed by the issuer as a sell-to-cover for RSU vesting tax withholding, leaving Nouri with 127,737 directly held shares.